• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Grupo Iusacell SA ADR

Grupo Iusacell SA ADR

  1. All
  2. 3rd Party
  1. CEL -SCI Reports Monthly Patient Enrollment in May for Its Phase 3 Head and Neck Cancer Trial

    CEL -SCI Reports Monthly Patient Enrollment in May for Its Phase 3 Head and Neck Cancer Trial

  2. Amid Turmoil, Don’t Discount Foreign Equities

    Use this screen to find overlooked small- and mid-capĀ international stocks.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.